Wave Life Sciences Ltd’s recent filing unveils that its Director Verdine Gregory L. unloaded Company’s shares for reported $0.21 million on Jun 13 ’25. In the deal valued at $6.95 per share,30,000 shares were sold. As a result of this transaction, Verdine Gregory L. now holds 282,517 shares worth roughly $2.22 million.
Then, GREGORY VERDINE bought 30,000 shares, generating $216,000 in total proceeds.
Before that, HENRY CHRISTIAN O sold 10,500 shares. Wave Life Sciences Ltd shares valued at $102,574 were divested by the Director at a price of $9.77 per share. As a result of the transaction, HENRY CHRISTIAN O now holds 16,115 shares, worth roughly $0.13 million.
Citigroup initiated its Wave Life Sciences Ltd [WVE] rating to a Buy in a research note published on July 16, 2025; the price target was $16. Cantor Fitzgerald began covering WVE with “an Overweight” recommendation on April 29, 2025. Wedbush started covering the stock on April 08, 2025. It rated WVE as “an Outperform”.
Price Performance Review of WVE
On Monday, Wave Life Sciences Ltd [NASDAQ:WVE] saw its stock fall -5.64% to $7.87. Over the last five days, the stock has gained 0.38%. Wave Life Sciences Ltd shares have risen nearly 33.16% since the year began. Nevertheless, the stocks have fallen -36.38% over the past one year.
How much short interest is there in Wave Life Sciences Ltd?
A steep rise in short interest was recorded in Wave Life Sciences Ltd stocks on 2025-06-13, dropping by -0.57 million shares to a total of 14.88 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 15.45 million shares. There was a decline of -3.82%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on February 25, 2025 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $26 price target.